
Thrombosis Update
@ThrombUpdate
Followers
917
Following
165
Media
181
Statuses
340
#OpenAccess journal publishing basic, translational and clinical research in #Thrombosis & #Haemostasis
Joined November 2019
New article in @ThrombUpdate 👇.Findings from a phase 2 trial show that Auxora™ may help patients with severe #COVID19 by reducing D-dimer levels. @LucyNORTCD #TruJournal.Rear more here:.
0
0
2
A new study in @ThrombUpdate reveals what patients value in thrombosis care! .Clear info & respectful relationships are key to satisfaction, but virtual options and affordable medication are areas for improvement. @LucyNORTCD #TruJournal.Read more here:.
0
0
1
A new study in @ThrombUpdate shows that freezing plasma samples doesn't significantly affect #thrombin generation measurements over long-term storage (up to 2 years at -80°C). @LucyNORTCD #TruJournal.Read more here:.
0
0
1
A new multicenter study in @ThrombUpdate from Colombia characterizes anticoagulation reversal practices, revealing bleeding as the primary indication and warfarin as the most common anticoagulant. @LucyNORTCD #TruJournal. Read more here:.
0
0
1
In this @ThrombUpdate article, the authors found that underdosing #DOACs for nonvalvular atrial fibrillation is linked to higher risks of stroke and major bleeding compared to on-label dosing. Read more here: @LucyNORTCD #TruJournal
0
0
2
New study in @ThrombUpdate reveals a significant, often underestimated, risk of blood clots in IBD out-patients. They auhtors found 7.6% experienced a thromboembolic event in IBD patients. Read more here: @LucyNORTCD #TruJournal
1
0
4
A new case study in @ThrombUpdate on hereditary antithrombin deficiency (HATD) in pregnancy shows antithrombin clearance increases in the first and third trimesters, peaking around delivery. Read more here:.@LucyNORTCD #TruJournal
1
2
8
What goes into deciding about #Antithrombotic therapy for #cancer patients at end of life? 🤔.The #SERENITY project is finding out! . Read more here in @ThrombUpdate .@LucyNORTCD #TruJournal
0
4
9
New meta-analysis in @ThrombUpdate on aspirin for infective endocarditis reveals mixed results for preventing embolic events. Read more here:.@LucyNORTCD #TruJournal
0
0
1
Why is #VTE mortality falling in Finland🇫🇮 despite soaring #PE incidence? 📉 .A nationwide registry study in @ThrombUpdate reveals key trends, including stable DVT rates & a surge in diagnostic imaging. Important and🗝️ findings for #VTE epidemiology. @LucyNORTCD #TruJournal
1
1
3
Safe #PE treatment for #cancer patients? .Ultrasound-guided thrombolysis #CDT shows promise! New study in @ThrombUpdate found similar low bleeding rates in cancer & non-cancer patients. Read more here:. @LucyNORTCD #TruJournal
0
1
8
From molecular mechanisms to clinical breakthroughs, @ThrombUpdate covers it all! . Submit your original research, reviews, or case reports today. #TruJournal @LucyNORTCD @emmpapadoc .
0
0
1
Is there a better way to predict pulmonary thromboembolism #PTE mortality? 🤔 . New research in @ThrombUpdate says RV/LV ratio on #CTPA might be the key. Find out how:. @LucyNORTCD #TruJournal
0
1
4
Critically ill #COVID19 patients on heparin? .New study in @ThrombUpdate reveals aPTT & anti-Xa monitoring often clash, impacting bleeding risk. Switching to anti-Xa guidance? Could mean fewer #Bleeding events. Read more here:@LucyNORTCD #TruJournal
0
0
3
One size doesn't fit all: DOACs for VTE in inherited thrombophilia need tailored approaches. New findings in @ThrombUpdate emphasize patient-centered care. Read the full text here:.@LucyNORTCD #TruJournal
0
0
8
This new study in @ThrombUpdate investigates how multimorbidity and its severity, along with specific disease clusters, relate to the risk of #VTE. Read more here at: @LucyNORTCD #TruJournal
0
0
3
A study in @thrombUpdate found that rosuvastatin did not prevent thrombus formation nor speed up resolution. Intriguing implications for the complex interplay of thrombosis & inflammation remain. 🤔 .#VTE Read the full article to learn more!.@LucyNORTCD
0
5
7
This recent study in @ThrombUpdate compared the safety and effectiveness of using a reduced apixaban lead-in vs. full lead-in dosing in #VTE. Read more : @LucyNORTCD @emmpapadoc #ThrJournal
0
3
6
The recent @ThrombUpdate paper presents an overview of public involvement as a whole and specifically reflects on how it has added value, to an international cancer associated thrombosis #CAT research. #ThrJournal. Read more here:
0
2
4